Compugen (CGEN) Competitors

Opthea (NASDAQ:OPT) and Compugen (NASDAQ:CGEN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

Which has more volatility & risk, OPT or CGEN?

Opthea has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Compugen has a beta of 2.61, meaning that its share price is 161% more volatile than the S&P 500.

Do insiders and institutionals have more ownership in OPT or CGEN?

56.0% of Opthea shares are owned by institutional investors. Comparatively, 12.2% of Compugen shares are owned by institutional investors. 3.2% of Opthea shares are owned by company insiders. Comparatively, 9.5% of Compugen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the media refer more to OPT or CGEN?

In the previous week, Compugen had 6 more articles in the media than Opthea. MarketBeat recorded 8 mentions for Compugen and 2 mentions for Opthea. Opthea's average media sentiment score of 1.66 beat Compugen's score of 0.75 indicating that Opthea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Opthea	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Compugen	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is OPT or CGEN more profitable?

Opthea has a net margin of 0.00% compared to Compugen's net margin of -87.45%. Opthea's return on equity of 0.00% beat Compugen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Opthea	N/A	N/A	N/A
Compugen	-87.45%	-34.77%	-16.82%

Which has stronger valuation and earnings, OPT or CGEN?

Compugen has higher revenue and earnings than Opthea.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Opthea	$120K	4,373.61	-$220.24M	N/A	N/A
Compugen	$27.86M	4.60	-$14.23M	-$0.22	-6.52

Do analysts recommend OPT or CGEN?

Opthea presently has a consensus price target of $1.33, indicating a potential downside of 60.90%. Compugen has a consensus price target of $4.00, indicating a potential upside of 178.75%. Given Compugen's stronger consensus rating and higher possible upside, analysts plainly believe Compugen is more favorable than Opthea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Opthea	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.17
Compugen	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Compugen beats Opthea on 8 of the 15 factors compared between the two stocks.